Skip to main content

Table 1 Inclusion and Exclusion criteria for subjects in study

From: Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women

Inclusion Criteria

Exclusion Criteria

• Women in first 5 years of menopause

• BMO T Score < -2.5 at hip or spine (osteoporosis)

• BMD T score between -1.0 and -2.49 at total hip or L1L4 spine (osteoporosis)

• Increased hip and major fracture based on FRAX score

• 19 years of age or older

• Bisphosphonates in last 6 months

• Health care provider’s permission to be in study

• Currently on estrogen, tamoxifen, Aromatase Inhibitors, others

 

• Weight > 300 pounds

 

• Serum Vitamin D <10 ng/ml or >100 ng/ml

 

• Any conditions that prohibit optimal CaD, risedronate, or exercise